Boehringer Ingelheim on Diversity

Nancy Di Dia, current Executive Director and Chief Diversity Officer at pharmaceutical giant Boehringer Ingelheim is known to be responsible for creating an inclusive environment for the company’s 9,300 employees in the United States. Since her arrival, she has jump-started the company’s strategy: creating a 23-person National Diversity & Inclusion Advisory Council that’s chaired by the CEO; identifying senior leaders to sponsor Boehringer Ingelheim’s six employee-resource groups; and encouraging employee-resource-group members to collaborate with the branding team so drug advertisements and marketing materials resonate with targeted communities. In addition, Di Dia has approved and co-designed mandatory diversity training to all full-time U.S. employees, and she has worked to expand the non-discrimination policy to include gender identity and expression. As a result, Boehringer Ingelheim has earned a perfect score on the Human Rights Campaign Corporate Equality Index for three consecutive years. “We’ve become a center of excellence,” says Di Dia, an open lesbian. Next on the agenda: to “take an active role in helping form the global diversity and inclusion strategy for the company’s 40,000 employees worldwide,” she says.

english gender globality internationality inclusion lgbtqi*